Portfolio Holdings Detail for ISIN IE00BFYTYS33
Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /var/www/liquidata/show_ticker_holding_ETFs.php on line 67

Stock Name / Fund	iShares Edge MSCI World Value Factor UCITS USD Dist
Issuer	Blackrock
ETF Ticker	IWVG(GBP) LSE
ETF Ticker	IWVU(USD) LSE
ETF Ticker	IWVU.LS(USD) CXE
ETF Ticker	IWVUx(GBP) CXE
ETF Ticker	IWVG.L(GBP) LSE
ETF Ticker	IWVU.L(GBP) LSE

Holdings detail for VTRS

Show aggregate VTRS holdings

News associated with VTRS

Notable ETF Inflow Detected - SPYD, CVS, VTRS, HPQ

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR Portfolio S&P 500 High Dividend ETF (Symbol: SPYD) where we have detected an approximate $224.1 million dollar inflow -- that's a 3.1% incre - 2025-09-05 11:52:24

Look Under The Hood: EPS Has 10% Upside

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-27 08:41:51

Viatris: FDA Approves First Generic Iron Sucrose Injection

(RTTNews) - Viatris (VTRS) announced the FDA has approved Iron Sucrose Injection, USP, an intravenous iron replacement product used to treat iron deficiency anemia in adult and pediatric patients with chronic kidney disease. The FDA granted Viatris a competitive generic therapy d - 2025-08-11 10:43:53

Viatris Reports Positive Data From Presbyopia Study

(RTTNews) - Viatris Inc. (VTRS), Thursday announced positive top-line results from VEGA-3, evaluating MR-141 in patients with presbyopia, the progressive loss of the ability to focus on close objects. - 2025-06-26 08:50:42

Do Wall Street Analysts Like Viatris Stock?

Viatris has underperformed the broader market over the past year, and analysts remain skeptical of the stock’s future potential. - 2025-05-07 12:38:15

Do Wall Street Analysts Like Viatris Stock?

Viatris has underperformed the broader market over the past year, and analysts remain skeptical of the stock’s future potential. - 2025-05-07 10:39:01

Do Wall Street Analysts Like Viatris Stock?

Viatris has underperformed the broader market over the past year, and analysts remain skeptical of the stock’s future potential. - 2025-05-07 08:37:13

What to Expect From Viatris' Q1 2025 Earnings Report

Viatris is scheduled to report its first-quarter results next month, and analysts expect a double-digit earnings drop. - 2025-04-28 10:58:09

Congress Trade: Representative Gilbert Ray Cisneros, Jr. Just Disclosed New Stock Trades

Representative Gilbert Ray Cisneros, Jr. just filed new stock trades, which we received from a STOCK Act disclosure. You can see the full list of trades on Quiver Quantitative's congress trading dashboard, and track the portfolios of Representative Gilbert Ray Cisneros, Jr. and o - 2025-04-08 11:02:22

How Is Viatris’ Stock Performance Compared to Other Biotech Stocks?

Over the past six months, Viatris has lagged behind its biotech peers, and Wall Street analysts continue to exercise caution regarding the stock's future outlook. - 2025-04-01 09:11:05

Sum Up The Pieces: RPV Could Be Worth $108

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-03-20 08:35:50

Chip Stock Weakness and Tariff Angst Sink Stocks

The S&P 500 Index ($SPX ) (SPY ) Thursday closed down -1.59%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.45% and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -2.75%. March E-mini S&P futures (ESH25 ) are down -1.56%, and March E-mini Nasdaq futures... - 2025-02-28 12:31:03

Nasdaq Slumps on Nvidia Weakness as Tariff Anxieties Loom Large

The S&P 500 Index ($SPX ) (SPY ) today is down -1.20%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.39%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.35%. March E-mini S&P futures (ESH25 ) are down -1.34%, and March E-mini Nasdaq futures... - 2025-02-27 19:45:02

Stocks Trade Mixed as Chip Stocks Slide

The S&P 500 Index ($SPX ) (SPY ) today is down -0.07%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.74%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.67%. March E-mini S&P futures (ESH25 ) are down -0.10%, and March E-mini Nasdaq futures... - 2025-02-27 18:41:22

Stocks Give Up Early Gains on Tariff Concerns

The S&P 500 Index ($SPX ) (SPY ) today is down -0.34%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.27%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.79%. March E-mini S&P futures (ESH25 ) are down -0.44%, and March E-mini Nasdaq futures... - 2025-02-27 18:23:08

Daily Dividend Report: NVDA,ALL,RY,TD,VTRS

NVIDIA will pay its next quarterly cash dividend of $0.01 per share on April 2, 2025, to all shareholders of record on March 12, 2025. Allstate announced that its board of directors approved a quarterly common stock dividend of $1.00 on Feb. 26, 2025, which is an increase of $0 - 2025-02-27 15:01:58

Viatris Stock Outlook: Is Wall Street Bullish or Bearish?

As Viatris has trailed the broader market over the past year, analysts are skeptical about its future outlook. - 2025-02-05 10:35:40

After Hours Most Active for Jan 31, 2025 : NVDA, VTRS, GRAB, AAPL, VZ, HRL, WBD, DOC, IP, ES, GOOGL, KIM

The NASDAQ 100 After Hours Indicator is down -17.78 to 21,460.27. The total After hours volume is currently 176,419,368 shares traded.The following are the most active stocks for the after hours session: NVIDIA Corporation (NVDA) is +0.2393 at $120.31, with 11,968,760 shares tra - 2025-01-31 19:24:54

S&P 500 Movers: TXT, NFLX

In early trading on Wednesday, shares of Netflix topped the list of the day's best performing components of the S&P 500 index, trading up 12.9%. Year to date, Netflix registers a 10.2% gain. And the worst performing S&P 500 component thus far on the day is Textron, tra - 2025-01-22 13:19:25

iShares Edge MSCI World Value Factor UCITS USD Dist VTRS holdings

Share Trades of VTRS by Blackrock for IE00BFYTYS33

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-05-27	SELL	-7,381	8.600	8.630	8.627	USD -63,676	10.54 Profit of 14,107 on sale
2025-05-19	SELL	-5,384	8.760	8.810	8.805	USD -47,406	10.62 Profit of 9,782 on sale
2025-05-15	SELL	-5,336	8.790	8.820	8.817	USD -47,048	10.65 Profit of 9,766 on sale
2025-05-14	SELL	-2,652	8.420	8.780	8.744	USD -23,189	10.66 Profit of 5,089 on sale
2025-04-24	SELL	-1,352	8.030	8.130	8.120	USD -10,978	10.90 Profit of 3,755 on sale
2025-04-22	SELL	-2,034	7.690	7.760	7.753	USD -15,770	10.95 Profit of 6,497 on sale
2025-04-10	BUY	2,670	7.260	7.610	7.575	USD 20,225	11.18
2025-04-09	BUY	2,308	7.790	7.870	7.862	USD 18,145	11.21
2025-04-07	SELL	-10,708	7.610	7.780	7.763	USD -83,126	11.28 Profit of 37,637 on sale
2025-04-01	SELL	-5,354	8.600	8.720	8.708	USD -46,623	11.36 Profit of 14,191 on sale
2025-03-28	BUY	2,671	8.680	8.900	8.878	USD 23,713	11.41
2025-03-21	BUY	2,653	9.150	9.370	9.348	USD 24,800	11.52
2025-03-19	BUY	2,665	9.420	9.700	9.672	USD 25,776	11.56
2025-03-11	BUY	5,330	9.340	9.510	9.493	USD 50,598	11.71
2025-03-07	BUY	5,286	9.650	9.740	9.731	USD 51,438	11.75
2025-02-28	BUY	27,691	9.230	9.720	9.671	USD 267,800	11.86
2025-02-20	BUY	2,550	11.060	11.100	11.096	USD 28,295	11.92
2025-02-03	SELL	-12,690	11.040	11.210	11.193	USD -142,039	12.12 Profit of 11,826 on sale
2025-01-31	SELL	-2,544	11.280	11.430	11.415	USD -29,040	12.14 Profit of 1,837 on sale
2025-01-23	SELL	-2,538	11.140	11.230	11.221	USD -28,479	12.22 Profit of 2,528 on sale
2025-01-13	BUY	2,538	11.800	11.800	11.800	USD 29,948	12.33
2024-12-30	SELL	-76,562	12.380	12.480	12.470	USD -954,728	12.36 Loss of -8,707 on sale
2024-12-09	SELL	-2,551	12.800	12.860	12.854	USD -32,791	12.34 Loss of -1,301 on sale
2024-12-04	SELL	-2,551	13.040	13.070	13.067	USD -33,334	12.31 Loss of -1,934 on sale
2024-11-29	SELL	-5,102	13.090	13.240	13.225	USD -67,474	12.25 Loss of -4,954 on sale
2024-11-25	SELL	-167,974	13.360	13.550	13.531	USD -2,272,856	12.10 Loss of -240,825 on sale
2024-11-25	SELL	-167,974	13.360	13.550	13.531	USD -2,272,856	12.10 Loss of -240,825 on sale
2024-11-22	SELL	-3,117	13.370	13.500	13.487	USD -42,039	12.06 Loss of -4,442 on sale
2024-11-21	SELL	-3,117	13.250	13.330	13.322	USD -41,525	12.03 Loss of -4,033 on sale
2024-11-05	SELL	-3,117	11.610	11.630	11.628	USD -36,244	11.62 Loss of -32 on sale
2024-11-05	SELL	-3,117	11.610	11.630	11.628	USD -36,244	11.62 Loss of -32 on sale

Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of VTRS

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy